A carregar...
OnabotulinumtoxinA Is an Effective Treatment for Chronic Migraine in Patients With Comorbid Fibromyalgia
Introduction: Fibromyalgia (FM) is a frequent comorbidity in patients with chronic migraine (CM). PREEMPT trials, which demonstrated the efficacy of OnabotulinumtoxinA (OnabotA) on CM, excluded patients with FM. Our aim was to evaluate the effectiveness of OnabotA in a series of patients with CM and...
Na minha lista:
| Main Authors: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020-10-01
|
| Colecção: | Frontiers in Neurology |
| Assuntos: | |
| Acesso em linha: | https://www.frontiersin.org/article/10.3389/fneur.2020.575130/full |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|